Publications by authors named "R Haw"

Germline and somatic mutations can give rise to proteins with altered activity, including both gain and loss-of-function. The effects of these variants can be captured in disease-specific reactions and pathways that highlight the resulting changes to normal biology. A disease reaction is defined as an aberrant reaction in which a variant protein participates.

View Article and Find Full Text PDF

The Reactome Knowledgebase (https://reactome.org), an Elixir and GCBR core biological data resource, provides manually curated molecular details of a broad range of normal and disease-related biological processes. Processes are annotated as an ordered network of molecular transformations in a single consistent data model.

View Article and Find Full Text PDF

Disease variant annotation in the context of biological reactions and pathways can provide a standardized overview of molecular phenotypes of pathogenic mutations that is amenable to computational mining and mathematical modeling. Reactome, an open source, manually curated, peer-reviewed database of human biological pathways, provides annotations for over 4000 disease variants of close to 400 genes in the context of ∼800 disease reactions constituting ∼400 disease pathways. Functional annotation of disease variants proceeds from normal gene functions, through disease variants whose divergence from normal molecular behaviors has been experimentally verified, to extrapolation from molecular phenotypes of characterized variants to variants of unknown significance using criteria of the American College of Medical Genetics and Genomics (ACMG).

View Article and Find Full Text PDF
Article Synopsis
  • Dark proteins hold promise for discovering new molecular mechanisms related to diseases and could lead to innovative therapies.
  • The Reactome-IDG project aims to analyze dark proteins by integrating them into reliable biological pathways, enabling researchers to understand their functions better.
  • The Reactome-IDG web portal allows users to explore these pathways interactively, offering tools to visualize relationships and interactions relevant to dark proteins and their potential therapeutic uses.
View Article and Find Full Text PDF